A

Apeloa Pharmaceutical Co Ltd
SZSE:000739

Watchlist Manager
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Watchlist
Price: 16.07 CNY 1.84% Market Closed
Market Cap: 18.8B CNY
Have any thoughts about
Apeloa Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Apeloa Pharmaceutical Co Ltd stock under the Base Case scenario is 26.63 CNY. Compared to the current market price of 16.07 CNY, Apeloa Pharmaceutical Co Ltd is Undervalued by 40%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
26.63 CNY
Undervaluation 40%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
38
vs Industry
62
Median 3Y
1.7
Median 5Y
1.3
Industry
2.5
Forward
1.5
vs History
33
vs Industry
28
Median 3Y
17.8
Median 5Y
14.9
Industry
21.8
Forward
16
vs History
38
vs Industry
27
Median 3Y
15.3
Median 5Y
11.9
Industry
16.1
vs History
39
vs Industry
15
Median 3Y
24.7
Median 5Y
13.9
Industry
23.8
vs History
50
vs Industry
29
Median 3Y
3.7
Median 5Y
3.1
Industry
2.1
vs History
33
vs Industry
60
Median 3Y
1.7
Median 5Y
1.3
Industry
2.7
Forward
1.6
vs History
31
vs Industry
33
Median 3Y
7.2
Median 5Y
5.2
Industry
5.2
vs History
31
vs Industry
23
Median 3Y
17.3
Median 5Y
13.1
Industry
13.5
Forward
11.1
vs History
31
vs Industry
27
Median 3Y
17.3
Median 5Y
13.1
Industry
16.8
Forward
15
vs History
31
vs Industry
26
Median 3Y
15.2
Median 5Y
12.4
Industry
15.2
vs History
28
vs Industry
12
Median 3Y
26.1
Median 5Y
-168.2
Industry
19.3
vs History
50
vs Industry
35
Median 3Y
3.2
Median 5Y
2.4
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Apeloa Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Apeloa Pharmaceutical Co Ltd
SZSE:000739
18.8B CNY 1.5 17.5 16.7 16.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
749.1B USD 18.5 89.9 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
348B USD 4 23.7 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
150.1B USD 2.5 35.4 10.5 15.9
P/E Multiple
Earnings Growth P/E to Growth
CN
A
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Average P/E: 30.7
17.5
51%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
89.9
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.7
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.4
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
A
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Average EV/EBITDA: 415.2
16.7
103%
0.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.1
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.5
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
A
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Average EV/EBIT: 1 811.8
16.7
54%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.7
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
14.9
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
15.9
68%
0.2

See Also

Discover More
Back to Top